StonvexLoading…
StonvexCore line items from BKKT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Q2 2025 2025-06-30 | Q1 2025 2025-03-31 | Annual 2024 2024-12-31 |
|---|---|---|---|---|
Revenue | $2.34B | $1.65B | $1.07B | $3.44B |
Operating Income | $-147.84M | $-37.01M | $-15.44M | $-82.59M |
Net Income | $-107.21M | $-7.03M | $7.71M | $-46.66M |
EPS (Diluted) | $-8.87 | $-1.05 | $1.13 | $-7.97 |
Total Assets | $162.79M | $190.14M | $176.35M | $269.38M |
Total Liabilities | $50.01M | $132.31M | $94.79M | $206.52M |
Cash & Equivalents | $26.96M | $43.49M | $23.01M | $39.05M |
Free Cash Flow OCF − CapEx | Not available | $-96.08M | $-101.41M | $-24.29M |
Shares Outstanding | 25.52M | 6.68M | 7.17M | 5.86M |